Abortion drug ‘Mifepristone’ will be available in America… Supreme Court denies ban request
The Supreme Court of the United States has made a great decision in favor of women.
Abortion drug mifepristone won’t be banned – U.S. Supreme Court
Washington: The United States Supreme Court issued a landmark ruling in favor of women on Friday. The court refused to ban “mifepristone”, a widely used abortion pill. The court suspended the new restrictions set by the lower courts. The court rejected the new restrictions set by the lower courts. Two conservative judges disagree on this decision.
The case stems from a decision by a U.S. District Court judge in Texas that banned mifepristone. US President Joe Biden’s administration appealed the Texas decision and asked to suspend the Texas court order.
Mifepristone was developed by French researchers in 1980. Mifepristone was approved for abortion in France and was adopted in other countries over the following years. In 2000, the United States Food and Drug Administration (FDA) approved the use of mifepristone. As per the rule, this drug is intended to terminate pregnancies up to seven weeks in the United States. It can only be delivered directly to users in clinics, medical practices and hospitals.
According to the Guttmacher Institute, 53% of the 930,160 abortions documented by the Organization for Reproductive Health Research and Policy in the United States in 2020 were abortions. Took the pill. This figure was 17% in 2008 and 39% in 2017. In recent years, there has been an increase in the number of abortions in the United States. Anti-abortion groups led by the newly formed Coalition for Hippocratic Medicine and four anti-abortion doctors sued the FDA in November. They argued the agency used an illegal process to approve the drug, which they considered unsafe.
Read the latest news in America for the first time News84Media America | Read today’s latest news, live updates, the most trusted America news website, News84Media America.
Tags: abortion, American News
FIRST POST: April 22, 2023, 08:27 HST